[{"address1": "2 Holzman Street", "address2": "Science Park PO Box 4081", "city": "Rehovot", "zip": "7670402", "country": "Israel", "phone": "972 8 940 6472", "fax": "972 8 940 6473", "website": "https://www.kamada.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for various immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for prevention of hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX to treat hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for salmonella typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; RYPLAZIM for hypoplasminogenemia; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.", "fullTimeEmployees": 420, "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  London", "age": 55, "title": "Chief Executive Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 674000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chaime  Orlev", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eran  Nir", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 417000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon R. Knight", "age": 58, "title": "Vice President of US Commercial Operations", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 302000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Boris  Gorelik", "age": 42, "title": "Vice President of Business Development & Strategic Programs", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 392000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Tsur", "age": 74, "title": "Co-Founder & Independent Deputy Chairman of the Board", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nir  Livneh B.A., L.L.B.", "age": 44, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hanni  Neheman", "age": 54, "title": "Vice President of Marketing & Sales", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Liron  Reshef", "age": 52, "title": "Vice President of Human Resources", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shavit  Beladev", "title": "Vice President of Kamada Plasma", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.74, "open": 6.66, "dayLow": 6.56, "dayHigh": 6.69, "regularMarketPreviousClose": 6.74, "regularMarketOpen": 6.66, "regularMarketDayLow": 6.56, "regularMarketDayHigh": 6.69, "exDividendDate": 1742169600, "payoutRatio": 0.0, "beta": 0.148, "trailingPE": 23.678572, "forwardPE": 21.387096, "volume": 64558, "regularMarketVolume": 64558, "averageVolume": 110936, "averageVolume10days": 101210, "averageDailyVolume10Day": 101210, "bid": 6.61, "ask": 6.7, "bidSize": 1, "askSize": 2, "marketCap": 391642720, "fiftyTwoWeekLow": 4.74, "fiftyTwoWeekHigh": 9.15, "priceToSalesTrailing12Months": 2.3418705, "fiftyDayAverage": 6.6172, "twoHundredDayAverage": 6.2498, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 310295424, "profitMargins": 0.09604, "floatShares": 9044715, "sharesOutstanding": 57505000, "sharesShort": 32709, "sharesShortPriorMonth": 34151, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.00059999997, "heldPercentInsiders": 0.07217, "heldPercentInstitutions": 0.48654, "shortRatio": 0.33, "shortPercentOfFloat": 0.001, "impliedSharesOutstanding": 59071300, "bookValue": 4.449, "priceToBook": 1.4902226, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "earningsQuarterlyGrowth": 0.676, "netIncomeToCommon": 16061000, "trailingEps": 0.28, "forwardEps": 0.31, "enterpriseToRevenue": 1.855, "enterpriseToEbitda": 8.502, "52WeekChange": 0.26526713, "SandP52WeekChange": 0.09362543, "lastDividendValue": 0.2, "lastDividendDate": 1742169600, "quoteType": "EQUITY", "currentPrice": 6.63, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 14.75, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 76250000, "totalCashPerShare": 1.346, "ebitda": 36497000, "totalDebt": 11098000, "quickRatio": 1.931, "currentRatio": 3.304, "totalRevenue": 167235008, "debtToEquity": 4.405, "revenuePerShare": 2.941, "returnOnAssets": 0.04143, "returnOnEquity": 0.06444, "grossProfits": 73965000, "freeCashflow": 36833248, "operatingCashflow": 46061000, "earningsGrowth": 0.75, "revenueGrowth": 0.166, "grossMargins": 0.44228, "ebitdaMargins": 0.21824, "operatingMargins": 0.17708999, "financialCurrency": "USD", "symbol": "KMDA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Kamada Ltd.", "longName": "Kamada Ltd.", "averageDailyVolume3Month": 110936, "fiftyTwoWeekLowChange": 1.8900003, "fiftyTwoWeekLowChangePercent": 0.39873427, "fiftyTwoWeekRange": "4.74 - 9.15", "fiftyTwoWeekHighChange": -2.5199995, "fiftyTwoWeekHighChangePercent": -0.2754098, "fiftyTwoWeekChangePercent": 26.526714, "dividendDate": 1743984000, "earningsTimestamp": 1747220403, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "earningsCallTimestampStart": 1747225800, "earningsCallTimestampEnd": 1747225800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.28, "epsForward": 0.31, "epsCurrentYear": 0.3275, "priceEpsCurrentYear": 20.244276, "fiftyDayAverageChange": 0.012800217, "fiftyDayAverageChangePercent": 0.0019343856, "twoHundredDayAverageChange": 0.3801999, "twoHundredDayAverageChangePercent": 0.06083393, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1370007000000, "postMarketChangePercent": -0.754151, "postMarketPrice": 6.58, "postMarketChange": -0.0500002, "regularMarketChange": -0.10999966, "regularMarketDayRange": "6.56 - 6.69", "fullExchangeName": "NasdaqGS", "corporateActions": [], "postMarketTime": 1748033944, "regularMarketTime": 1748030401, "exchange": "NMS", "messageBoardId": "finmb_9002466", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.6320424, "regularMarketPrice": 6.63, "displayName": "Kamada", "trailingPegRatio": 0.7829, "__fetch_time": "2025-05-24"}]